Annals of internal medicine
-
The long-term risk for major bleeding in patients receiving extended (beyond the initial 3 to 6 months) anticoagulant therapy for a first unprovoked venous thromboembolism (VTE) is uncertain. ⋯ Canadian Institutes of Health Research. (PROSPERO: CRD42019128597).
-
Remdesivir is being studied and used for treatment of coronavirus disease 2019 (COVID-19). ⋯ U.S. Department of Veterans Affairs.
-
Nasopharyngeal swabs are the primary sampling method used for detection of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), but they require a trained health care professional and extensive personal protective equipment. ⋯ McGill Interdisciplinary Initiative in Infection and Immunity. (PROSPERO: CRD42020203415).
-
Although intensive blood pressure (BP)-lowering treatment reduces risk for cardiovascular disease, there are concerns that it might cause orthostatic hypotension (OH). ⋯ National Heart, Lung, and Blood Institute, National Institutes of Health. (PROSPERO: CRD42020153753).
-
Strategies to improve patients' tolerance of and adherence to statins may enhance the effectiveness of dyslipidemia treatment in those at risk for cardiovascular disease (CVD). ⋯ U.S. Department of Veterans Affairs.